Transcutaneous immunization using microneedles and cubosomes: Mechanistic investigations using Optical Coherence
Teerawan Rattanapak1, James Birchall, Katherine Young
1New Zealand's National School of Pharmacy, University of Otago, New Zealand.
Summary
Transcutaneous immunization offers advantages, but skin penetration is a challenge. Combining microneedles with cubosomes shows potential for effective skin-based vaccine delivery to immune cells.
Area of Science:
- Biomedical Engineering
- Dermatology
- Vaccinology
Background:
- Transcutaneous immunization (TCI) presents a needle-free vaccination alternative with significant benefits.
- A primary obstacle to TCI is the stratum corneum (SC) barrier, hindering antigen penetration to deeper skin layers.
- Strategies like microneedles (MNs) and advanced delivery systems are explored to overcome SC penetration challenges.
Purpose of the Study:
- To evaluate the synergistic potential of microneedles (MNs) and cubosomes for enhancing transcutaneous vaccine delivery.
- To investigate the penetration and permeation of peptide antigens through the skin using this combined approach.
Main Methods:
- Utilized microneedles (MNs) and lipid-based cubosomes for antigen delivery.
- Employed Optical Coherence Tomography and two-photon microscopy for quantitative and qualitative analysis of skin penetration.
- Assessed the permeation of an aqueous peptide mixture, cubosome-formulated peptide, and cubosomes through skin.
Main Results:
- Microneedles alone enhanced the permeation of an aqueous peptide mixture through the skin.
- Cubosomes, both with and without peptide, were observed to be retained within the skin layers.
- The study demonstrated differential penetration characteristics of MNs and cubosomes.
Conclusions:
- A combined approach utilizing microneedles and cubosomes is proposed as an effective strategy for localized antigen delivery.
- This synergistic system aims to target immunocompetent cells within the skin for enhanced immune responses.
- Further research is warranted to optimize this combined delivery system for transcutaneous immunization applications.


